Search Result "nash"
Emerging Therapies and Therapeutic Targets for Composite LiverDisease: NASH
Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 21 Year: 2023 Page: 2027-2047
Author(s): M. Elizabeth Sobhia
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5239-5249
Author(s): Samuele De Minicis, Chris Day, Gianluca Svegliati-Baroni
Managing Patients Differently - The Scottish National Sexual Health IT System (NaSH)
Ebook: Transforming Sexual Health in Scotland: Cultural, Organisational and Partnership Approaches
Volume: 1 Year: 2010
Author(s): Andrew J Winter
Doi: 10.2174/978160805065911001010045
Prebiotics and Probiotics: Effects on Dyslipidemia and NAFLD/NASH andthe Associated Mechanisms of Action
Journal: Current Pharmaceutical Biotechnology
Volume: 24 Issue: 5 Year: 2023 Page: 633-646
Author(s): Luis E. Soria-Jasso
NAFLD-NASH: An Under-Recognized Epidemic
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 209-213
Author(s): Joseph Jennings,Charles Faselis,Michael D. Yao
Uric Acid Elevation by Fructose Overload Exacerbates Nash and Atherosclerosis via Oxidative Stress
Journal: Current Nutrition & Food Science
Volume: 20 Issue: 2 Year: 2024 Page: 250-261
Author(s):
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 246-253
Author(s): Vasilios G. Athyros,Chrysa Boutari,Konstantinos Stavropoulos,Panagiotis Anagnostis,Konstantinos P. Imprialos,Michael Doumas,Asterios Karagiannis
Editorial: Exploring Lipid-related Treatment Options for the Treatment of NASH
Journal: Current Vascular Pharmacology
Volume: 12 Issue: 5 Year: 2014 Page: 741-744
Author(s): Manfredi Rizzo,Giuseppe Montalto,Manlio Vinciguerra
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5219-5238
Author(s): Paola Dongiovanni, Quentin M. Anstee, Luca Valenti
The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 254-268
Author(s): Marianna Papademetriou,Vasilios G. Athyros,Eleni Geladari,Michael Doumas,Costas Tsioufis,Vasilios Papademetriou